Strategic Insight reports are designed to support strategic objectives and planning by Integrated Care System leaders. Through the analysis of data and communication with key stakeholders across the ICS, interventions to be undertaken by the ICS are proposed to Integrated Care Boards or associated committees.

Social prescribing has been proposed as a mechanism to improve the health of populations while reducing or avoiding pharmacological treatment, thereby reducing overprescribing. This report provides an overview of the evidence for the effectiveness of social prescribing and evaluates the impact of a large social prescribing scheme on primary care prescribing of medicines.

This publication is part of our Strategic Support and Planning contract. To gain access please email us at nuth.nyrdtc.rxsupp@nhs.net.